Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
Ardelyx, Inc., a biopharmaceutical company specializing in innovative medicines, will report its second quarter 2026 financial results on August 6, 2026. Management will host a webcast and conference call to discuss the outcomes and provide a business update. The company currently markets two approved products in the US and continues development of…